サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：多血小板血漿（PRP）市場 - 成長、将来展望、競合分析、2023年～2031年
市場調査レポート
商品コード
1293851

多血小板血漿（PRP）市場 - 成長、将来展望、競合分析、2023年～2031年

Platelet Rich Plasma (PRP) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
多血小板血漿（PRP）市場 - 成長、将来展望、競合分析、2023年～2031年
出版日: 2023年05月06日
発行: Acute Market Reports
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多血小板血漿（PRP）市場は、2031年までに14.5％の成長が見込まれます。多血小板血漿（PRP）は、少量の血漿中に多数の血小板が含まれる製品です。PRPは、組織封止と止血特性を持つフィブリン組織接着剤として機能します。PRPが血小板の少ない組織やフィブリン接着剤と異なるのは、PRPが創傷治癒プロセスと骨形成を増強する独自の能力を提供するためです。PRPは、安全で生体適合性の高い迅速な止血剤として機能し、表皮、上皮、内皮の再生を早めます。PRPはコラーゲン合成を促進し、血管新生を促し、真皮の瘢痕を減らし、軟組織の治癒を増強し、グルココルチコイドによる治癒阻害を逆転させます。PRPに含まれる高濃度の白血球は、さらなる抗菌効果をもたらします。

PRPは、耳鼻咽喉科、一般外科、美容外科および美容整形外科、火傷および傷の治癒、心臓血管外科、口腔および顎顔面外科手術など、幅広い臨床治癒用途に使用されています。PRPは、慢性的な非治癒性創傷の治療に有効であることが証明されており、血管新生阻害剤としても採用されています。外科手術では、PRPはドナー部位とレシピエント部位の両方で術後および術前の出血のリスクを低減し、軟組織の治癒を増強し、接着性と凝集性の特性によりレシピエント部位での移植組織の安定性を促進します。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

第3章 多血小板血漿（PRP）市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 vs 2031

第4章 多血小板血漿（PRP）市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の多血小板血漿（PRP）市場金額 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 多血小板血漿（PRP）市場：タイプ別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 純粋PRP
    • 白血球を多く含むPRP
    • その他

第6章 多血小板血漿（PRP）市場：用途別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 整形外科
    • スポーツ医学
    • 美容整形
    • 皮膚科
      • 潰瘍の治癒
      • その他
    • 眼科手術
    • 脳神経外科
    • 一般外科
    • その他

第7章 多血小板血漿（PRP）市場：最終用途別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 病院
    • クリニック
    • その他

第8章 北米の多血小板血漿（PRP）市場 2021-2031

  • 市場概要
  • 多血小板血漿（PRP）市場：タイプ別 2021-2031
  • 多血小板血漿（PRP）市場：用途別 2021-2031
  • 多血小板血漿（PRP）市場：最終用途別 2021-2031
  • 多血小板血漿（PRP）市場：地域別 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国・欧州連合の多血小板血漿（PRP）市場 2021-2031

  • 市場概要
  • 多血小板血漿（PRP）市場：タイプ別 2021-2031
  • 多血小板血漿（PRP）市場：用途別 2021-2031
  • 多血小板血漿（PRP）市場：最終用途別 2021-2031
  • 多血小板血漿（PRP）市場：地域別 2021-2031
    • 英国・欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋の多血小板血漿（PRP）市場 2021-2031

  • 市場概要
  • 多血小板血漿（PRP）市場：タイプ別 2021-2031
  • 多血小板血漿（PRP）市場：用途別 2021-2031
  • 多血小板血漿（PRP）市場：最終用途別 2021-2031
  • 多血小板血漿（PRP）市場：地域別 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカの多血小板血漿（PRP）市場 2021-2031

  • 市場概要
  • 多血小板血漿（PRP）市場：タイプ別 2021-2031
  • 多血小板血漿（PRP）市場：用途別 2021-2031
  • 多血小板血漿（PRP）市場：最終用途別 2021-2031
  • 多血小板血漿（PRP）市場：地域別 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東・アフリカの多血小板血漿（PRP）市場 2021-2031

  • 市場概要
  • 多血小板血漿（PRP）市場：タイプ別 2021-2031
  • 多血小板血漿（PRP）市場：用途別 2021-2031
  • 多血小板血漿（PRP）市場：最終用途別 2021-2031
  • 多血小板血漿（PRP）市場：地域別 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Johnson & Johnson Services Inc.
  • Arthrex Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences Inc.
図表

List of Tables

  • TABLE 1 Global Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 4 Global Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 5 Global Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 6 North America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 7 North America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 8 North America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 9 North America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 10 North America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 11 U.S. Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 12 U.S. Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 13 U.S. Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 14 U.S. Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 15 U.S. Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 16 Canada Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 17 Canada Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 18 Canada Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 19 Canada Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 20 Canada Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 21 Rest of North America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 22 Rest of North America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Rest of North America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 24 Rest of North America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 26 UK and European Union Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 27 UK and European Union Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 28 UK and European Union Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 29 UK and European Union Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 30 UK and European Union Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 UK Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 32 UK Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 33 UK Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 34 UK Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 35 UK Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 36 Germany Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 37 Germany Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 38 Germany Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 39 Germany Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 40 Germany Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 41 Spain Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 42 Spain Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 43 Spain Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 44 Spain Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 45 Spain Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 46 Italy Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 47 Italy Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 48 Italy Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 49 Italy Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 50 Italy Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 51 France Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 52 France Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 53 France Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 54 France Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 55 France Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 56 Rest of Europe Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 57 Rest of Europe Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 58 Rest of Europe Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 59 Rest of Europe Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 60 Rest of Europe Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 Asia Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 62 Asia Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Asia Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 64 Asia Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 65 Asia Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 66 China Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 67 China Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 68 China Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 69 China Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 70 China Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 71 Japan Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 72 Japan Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 73 Japan Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 74 Japan Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 75 Japan Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 76 India Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 77 India Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 78 India Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 79 India Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 80 India Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 81 Australia Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 82 Australia Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 83 Australia Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 84 Australia Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 85 Australia Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 86 South Korea Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 87 South Korea Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 88 South Korea Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 89 South Korea Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 90 South Korea Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 91 Latin America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 92 Latin America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 93 Latin America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 94 Latin America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 95 Latin America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 96 Brazil Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 97 Brazil Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 98 Brazil Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 99 Brazil Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 100 Brazil Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 101 Mexico Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 102 Mexico Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 103 Mexico Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 104 Mexico Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 105 Mexico Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 106 Rest of Latin America Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 107 Rest of Latin America Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 108 Rest of Latin America Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 109 Rest of Latin America Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 110 Rest of Latin America Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 111 Middle East and Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 112 Middle East and Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 113 Middle East and Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 114 Middle East and Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 115 Middle East and Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 116 GCC Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 117 GCC Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 118 GCC Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 119 GCC Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 120 GCC Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 121 Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 122 Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 123 Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 124 Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 125 Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Type, 2021-2031, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Application, 2021-2031, USD (Million)
  • TABLE 128 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Dermatology, 2021-2031, USD (Million)
  • TABLE 129 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By Ulcer Healing, 2021-2031, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Platelet Rich Plasma (PRP) Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Platelet Rich Plasma (PRP) Market: Quality Assurance
  • FIG. 5 Global Platelet Rich Plasma (PRP) Market, By Type, 2022
  • FIG. 6 Global Platelet Rich Plasma (PRP) Market, By Application, 2022
  • FIG. 7 Global Platelet Rich Plasma (PRP) Market, By End-use, 2022
  • FIG. 8 Global Platelet Rich Plasma (PRP) Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Platelet Rich Plasma (PRP) Market, 2022
  • FIG. 10 Market Positioning of Key Platelet Rich Plasma (PRP) Market Players, 2022
  • FIG. 11 Global Platelet Rich Plasma (PRP) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Platelet Rich Plasma (PRP) Market, By Type, 2022 Vs 2031, %
  • FIG. 13 Global Platelet Rich Plasma (PRP) Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Platelet Rich Plasma (PRP) Market, By End-use, 2022 Vs 2031, %
  • FIG. 15 U.S. Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 22 France Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 24 China Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 26 India Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market (US$ Million), 2021 - 2031
目次
Product Code: 137082-05-23

Platelet Rich Plasma (PRP) Market is Expected to Grow at 14.5% by 2031. Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because PRP provides a unique ability to augment wound healing process and osteogenesis. PRP functions as a safe, biocompatible prompt hemostatic agent and fast-tracks epidermal, epithelial and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing and reverses inhibition of glucocorticoid would healing. High concentration of leukocyte in PRP offers additional antimicrobial effect.

PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery and aesthetics, burn and would healing, cardiovascular surgery, oral and maxillofacial surgical procedures and others. PRP has proven effectiveness in treating chronic non-healing wounds and has been adopted as antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability to grafted tissue at the recipient site owing to its adhesive and cohesive properties.

Key players identified for platelet rich plasma market include but are not limited to:

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Platelet Rich Plasma (PRP) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Platelet Rich Plasma (PRP) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Segmentation

Type

  • Pure Platelet Rich Plasma
  • Leukocyte Rich Platelet Rich Plasma
  • Others

Application

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
    • Ulcer Healing
      • Venous Ulcer
      • Traumatic Ulcer
      • Diabetic Ulcer
      • Pyoderma Gangrenosum Ulcer
      • Trophic Ulcer
      • Vasculitic Ulcer
      • Others
    • Others
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

End-use

  • Hospitals
  • Clinics
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Platelet Rich Plasma (PRP) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Platelet Rich Plasma (PRP) market?
  • Which is the largest regional market for Platelet Rich Plasma (PRP) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Platelet Rich Plasma (PRP) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Platelet Rich Plasma (PRP) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Platelet Rich Plasma (PRP) Market
  • 2.2. Global Platelet Rich Plasma (PRP) Market, By Type, 2022 (US$ Million)
  • 2.3. Global Platelet Rich Plasma (PRP) Market, By Application, 2022 (US$ Million)
  • 2.4. Global Platelet Rich Plasma (PRP) Market, By End-use, 2022 (US$ Million)
  • 2.5. Global Platelet Rich Plasma (PRP) Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Platelet Rich Plasma (PRP) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Platelet Rich Plasma (PRP) Market Vendors
  • 3.2. Strategies Adopted by Platelet Rich Plasma (PRP) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Platelet Rich Plasma (PRP) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Platelet Rich Plasma (PRP) Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Pure Platelet Rich Plasma
    • 5.3.2. Leukocyte Rich Platelet Rich Plasma
    • 5.3.3. Others

6. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Orthopedics
    • 6.3.2. Sports Medicine
    • 6.3.3. Cosmetic Surgery
    • 6.3.4. Dermatology
      • 6.3.4.1. Ulcer Healing
        • 6.3.4.1.1. Venous Ulcer
        • 6.3.4.1.2. Traumatic Ulcer
        • 6.3.4.1.3. Diabetic Ulcer
        • 6.3.4.1.4. Pyoderma Gangrenosum Ulcer
        • 6.3.4.1.5. Trophic Ulcer
        • 6.3.4.1.6. Vasculitic Ulcer
        • 6.3.4.1.7. Others
      • 6.3.4.2. Others
    • 6.3.5. Ophthalmic Surgery
    • 6.3.6. Neurosurgery
    • 6.3.7. General Surgery
    • 6.3.8. Others

7. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others

8. North America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 8.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 8.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 8.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 9.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 9.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 9.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 10.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 10.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 10.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

11. Latin America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 11.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 11.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 11.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 12.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 12.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 12.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Johnson & Johnson Services, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Arthrex, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. EmCyte Corporation
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Dr PRP USA LLC
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Juventix Regenerative Medical, LLC.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Terumo Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Zimmer Biomet
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Stryker
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Apex Biologix
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Celling Biosciences, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives